Tirtha Chakraborty is CHIEF SCIENTIFIC OFFICER of Vor Biopharma Inc.. Currently has a direct ownership of 171,796 shares of VOR, which is worth approximately $121,975. The most recent transaction as insider was on Sep 03, 2024, when has been sold 5,576 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $4,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K
4.15% 3M change
27.42% 12M change
Total Value Held $121,975

Tirtha Chakraborty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Payment of exercise price or tax liability
$4,628 $0.83 p/Share
5,576 Reduced 3.14%
171,796 Common Stock
Aug 06 2024
SELL
Payment of exercise price or tax liability
$762 $0.87 p/Share
876 Reduced 0.49%
177,372 Common Stock
Aug 01 2024
SELL
Payment of exercise price or tax liability
$925 $0.94 p/Share
985 Reduced 0.55%
178,248 Common Stock
May 06 2024
SELL
Payment of exercise price or tax liability
$1,531 $1.75 p/Share
875 Reduced 0.49%
179,233 Common Stock
May 01 2024
SELL
Payment of exercise price or tax liability
$1,743 $1.77 p/Share
985 Reduced 0.54%
180,108 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$12,657 $2.27 p/Share
5,576 Reduced 2.99%
181,093 Common Stock
Feb 06 2024
SELL
Payment of exercise price or tax liability
$2,396 $2.32 p/Share
1,033 Reduced 0.55%
186,669 Common Stock
Jan 29 2024
BUY
Grant, award, or other acquisition
-
53,750 Added 22.26%
187,702 Common Stock
Nov 06 2023
SELL
Payment of exercise price or tax liability
$1,594 $1.82 p/Share
876 Reduced 0.65%
133,952 Common Stock
Sep 01 2023
SELL
Payment of exercise price or tax liability
$14,887 $2.67 p/Share
5,576 Reduced 3.97%
134,828 Common Stock
Aug 07 2023
SELL
Payment of exercise price or tax liability
$2,336 $2.67 p/Share
875 Reduced 0.62%
140,404 Common Stock
May 08 2023
SELL
Payment of exercise price or tax liability
$3,622 $4.14 p/Share
875 Reduced 0.62%
141,279 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$30,723 $5.51 p/Share
5,576 Reduced 3.77%
142,154 Common Stock
Feb 06 2023
BUY
Grant, award, or other acquisition
-
47,750 Added 24.43%
147,730 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
76,000 Added 43.94%
96,980 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$23,727 $1.36 p/Share
17,446 Added 45.4%
20,980 Common Stock
Feb 09 2021
BUY
Conversion of derivative security
-
3,534 Added 50.0%
3,534 Common Stock
TC

Tirtha Chakraborty

CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on VOR

Follow Vor Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VOR shares.

Notify only if

Insider Trading

Get notified when an Vor Biopharma Inc. insider buys or sells VOR shares.

Notify only if

News

Receive news related to Vor Biopharma Inc.

Track Activities on VOR